QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 165 filers reported holding QIAGEN NV in Q4 2013. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $756,000 | +7.4% | 30,000 | 0.0% | 0.05% | +4.5% |
| Q4 2014 | $704,000 | +3.1% | 30,000 | 0.0% | 0.04% | +2.3% |
| Q3 2014 | $683,000 | -6.9% | 30,000 | 0.0% | 0.04% | -2.3% |
| Q2 2014 | $734,000 | +16.0% | 30,000 | 0.0% | 0.04% | +4.8% |
| Q1 2014 | $633,000 | -11.3% | 30,000 | 0.0% | 0.04% | -6.7% |
| Q4 2013 | $714,000 | +11.2% | 30,000 | 0.0% | 0.04% | -2.2% |
| Q3 2013 | $642,000 | +7.5% | 30,000 | 0.0% | 0.05% | -11.5% |
| Q2 2013 | $597,000 | – | 30,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tikvah Management LLC | 369,425 | $9,032,000 | 6.36% |
| Hardman Johnston Global Advisors LLC | 4,586,856 | $112,149,000 | 5.99% |
| Eclectica Asset Management LLP | 90,950 | $2,223,000 | 2.21% |
| Douglas C. Lane & Associates, Inc. | 1,970,371 | $48,176,000 | 1.46% |
| HARDING LOEVNER LP | 6,978,369 | $170,621,000 | 1.27% |
| CRAMER ROSENTHAL MCGLYNN LLC | 3,911,835 | $95,644,000 | 0.77% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,781,076 | $43,547,000 | 0.76% |
| GLG Partners LP | 1,220,148 | $29,833,000 | 0.71% |
| Sivik Global Healthcare LLC | 49,451 | $1,209,000 | 0.61% |
| PRIMECAP MANAGEMENT CO/CA/ | 22,087,404 | $540,037,000 | 0.59% |